Whether those effects translate directly to women in the GLP-1-therapy-plus-weight-loss context requires additional research that hasn't been published yet
Even before there is weight loss with these drugs, there is evidence from experimental models of reduced systemic (body-wide) and brain inflammation
Consider your medical history BMI and Comorbidities: GLP-1 agonists: Weight loss medications are an approved treatment for people with a Body Mass Index (BMI) over 30, or a BMI over 27 with at least one comorbidity like type 2 diabetes, hypertension or sleep apnea
(If opened and stored properly, the vial can often be used for days or weeks usually up to 28 days until the expiration date, as long as sterility is maintained.) Not a Medication By Itself: Bacteriostatic water has no pharmacological effect other than serving as a vehicle
If these experiments pan out, we could see clinical trials of drugs specifically tested to protect memory among older people
The introduction of beta-alanine in the body, and in turn, higher levels of carnosine act as a buffer against a drop in pH and reduce acidity levels in the muscles during exercises